Impact of Isotope Half-life: Long-vs. Short-Lived Radiotherapeutics and Differences in Manufacturing, Quality & Distribution to Clinic
Time: 1:30 pm
day: Conference Day One
Details:
- Impact of short vs long half-life isotopes on the manufacturing process and logistics to finished product
- Explore how established distribution models for isotopes like Lutetium-177 differ from those required for short half-life radiotherapies (Astatine-211), and what adaptations are needed.
- Discuss what elements of licensing, training, automation, packaging can be reused with both isotope types, and where entirely new systems are needed.
- Provide thoughts on manufacturing and clinical relevance of different isotope selection.
